Treatment with Efruxifermin over 24 weeks, a Fibroblast growth factor 21 (FGF21) analogue, improved liver fibrosis at least one stage in patients with F2 or F3 fibrosis (Harrison et al. 2023). This evidence concerns the gene FGF21 and Hepatic fibrosis.